-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Rubius Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2017 to Q4 2022.
- Rubius Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending December 31, 2022 was $2.96M.
- Rubius Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending December 31, 2022 was -$1.22M, a 36.8% increase year-over-year.
- Rubius Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was -$1.22M, a 36.8% increase from 2021.
- Rubius Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was -$1.93M, a 50.5% decline from 2020.
- Rubius Therapeutics, Inc. annual Nonoperating Income (Expense) for 2020 was -$1.28M, a 121% decline from 2019.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)